Investor mood around tobacco has quietly yet strongly improved lately. A sector that spent years in the ESG penalty box is back on buy lists, helped by robust consumer adoption in heated tobacco and oral nicotine. And while traditional combustible tobacco use is still trending down globally, pricing power in combustibles plus growth in the smoke-free categories have kept revenue and profit far more resilient than you’d expect from the volume charts.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Three tobacco stocks stand out for investors: British American Tobacco (BTI), Philip Morris International (PM), and Universal (UVV).
At the same time, the macro setting has shifted in their favour. With interest rates already cut modestly, and further cuts potentially on the way, long-term yields are drifting lower again. Given that tobacco stocks boast high yields and reliable dividends with multi-decade growth records, I believe investors will keep chasing them for their dependable income, thus pushing share prices in the space higher.
British American Tobacco (NYSE:BTI)
British American Tobacco (BTI) has rallied sharply in recent months, nearly doubling from last year’s lows. This has compressed its dividend yield from over 10% to just 5.4% today. And yet, I believe the stock is still a reliable income pick on which income investors will continue to flock to if the trend of declining interest rates endures. We are talking about one of the highest-quality British names. While its dividend growth track record may look choppy in USD terms, British American Tobacco has increased its dividend for 26 consecutive years in sterling terms, showcasing its ability (and the resilient nature of tobacco itself) to produce stable and predictable results under all sorts of economic environments.
Management is still guiding for 1–2% revenue growth in 2025 and has nudged its sales target higher after a better-than-expected first half, aided by improving U.S. trends and fast growth in modern oral nicotine. On recent calls, the message has been that free cash flow comfortably covers the dividend, leverage is edging down, and buybacks will continue in a measured way, all of which point to the bullish momentum remaining alive. After, even following its incredible rally, the stock is still trading at a forward P/E of 12.6x.
The problem is that BAT’s transformation still looks like a building site, because non-combustible “New Categories” account for a smaller share of revenue than at Philip Morris (PM), while illicit disposable vapes and a multi-billion-pound Canadian legal provision may drag on sentiment and capital. Still, the fundamentals remain rock-solid.
Is BTI Stock a Buy, Hold, or Sell?
Analyst sentiment remains scarce and is split on BTI, with the stock carrying a Moderate Buy consensus rating, based on one sell and one buy ratings on Wall Street. BTI’s average stock price target of $62 implies ~6% upside potential over the next twelve months.
Philip Morris International (NYSE:PM)
Phillip Morris currently offers a notably lower yield compared to BTI’s. Even after September’s 8.9% hike, the dividend yield is hovering close to 3.5% these days. The market is pricing this one at a premium and is willing to accept a lower yield since Philip Morris’ success in new categories has been phenomenal. In Q3, smoke-free products such as IQOS heated sticks and ZYN nicotine pouches generated around 40% of revenue and grew far faster (both at mid-teens rates) than the legacy cigarette portfolio, helping PMI beat earnings expectations and lift full-year profit guidance for the third time this year.
This may sound bizarre, but the company reminds me of tech innovators like Apple (AAPL) due to the “premiumization” of its devices. Its earnings calls often feel like consumer-tech presentations rather than updates from a cigarette business, with talk of device upgrades, conversion funnels, and a push to have smoke-free products account for roughly two-thirds of sales by 2030.
The risks have not disappeared, as nicotine pouches are still squarely in regulators’ sights and the payout ratio has occasionally run hotter than income purists would like, but the strategic direction is unusually clear for this industry, and Phillip Morris’ growth backs it up. Further, note that unlike Altria, which focuses domestically in the U.S., Philip Morris’ risk profile is much less concentrated, as it operates primarily internationally in more than 170 countries. This broader geographic footprint also helps explain why investors are willing to accept a below-average dividend yield.
Is PM Stock a Good Buy?
On Wall Street, Phillip Morris’ stock features a Strong Buy consensus rating, based on nine Buy and one Hold ratings. Not a single analyst rates PM stock a Sell. Moreover, PM’s average stock price target of $182.22 implies ~18% upside potential over the next 12 months.
Universal (NYSE:UVV)
Universal doesn’t sell brands to consumers at all. Instead, it buys, processes, and trades leaf and other agriproducts for the manufacturers, plus an ingredients segment that has been growing briskly. On the most recent report, management noted revenue rising on higher tobacco and ingredients volumes while achieving an earnings beat. I believe the positive trends in Universal’s results are likely to endure as its middleman role makes it less exposed to industry challenges and competition, as it sells leaves to all tobacco majors.
Another reason to like Universal is its dividend story, which few companies in the world can match. Specifically, Universal has increased its dividend every year since 1971, marking 56 consecutive years of hikes. Now, it’s true that Universal generates as much revenue as it did over 20 years ago, as its growth opportunities remain limited. Still, with the stock now offering a 6.3% yield and shares trading at roughly 11x earnings, Universal could prove a resilient income pick for conservative investors.
Management is candid about the risk of leaf oversupply and pricing pressure, but the balance sheet is relatively clean, and capital needs are modest, so a large slice of cash can still go to shareholders even if top-line growth never looks spectacular.
Is Universal a Buy, Hold, or Sell?
Currently, TipRanks is not tracking any analysts covering Universal. However, TipRanks does track hedge fund activity in the stock, and the smart institutional money seems to be about as cautious on the name. According to 13F filings from 487 hedge funds submitted to the SEC over the past quarter, hedge fund managers have decreased their stakes from almost 918K million shares in March to about 338 shares today.
Why Considering Tobacco Stocks May be a Good Idea
Overall, it seems that British American Tobacco gives you a fat payout but also comes with the most drama. Philip Morris has a smaller yield, but you get the clearest path toward a nicotine-with-less-risk future. Meanwhile, Universal Corporation essentially pays you to hold the crop trader in the background. Frankly, all three yield more than the overall market, and if interest rates keep drifting downward, they’re exactly the kind of stocks income-seekers tend to chase.